---
title: "Oura revenue and valuation"
description: "Oura's revenue is estimated at $1.08B–$2.01B, last reported at $1.4B. Valued at $11B after raising $1.5B. Funding rounds and competitors."
url: https://www.tryspecter.com/revenue-valuation/oura.md
canonical_url: https://www.tryspecter.com/revenue-valuation/oura
publisher: Specter
last_updated: 2026-11-01
---

# Oura revenue and valuation

Specter estimates Oura's annual revenue at $1.08B to $2.01B and its valuation at $11.6B to $15.3B. The company last reported $1.4B revenue in June 2026 and was priced at $11B in October 2025.

Oura makes a smart ring and app that track sleep, activity, and biometrics.

- Estimated revenue: $1.08B to $2.01B (October 2026)
- Estimated valuation: $11.6B to $15.3B (October 2026)
- Last reported revenue: $1.4B (June 2026)
- Total funding: $1.5B
- Founded: 2013
- Headquarters: San Francisco, United States
- Employees: 1,650
- Sector: Consumer health
- Specter Rank: #33,076

## Oura revenue

Oura grew from $500M revenue in December 2024 to $1.4B in June 2026. Specter's model puts current revenue between $1.08B and $2.01B, anchored to three reported figures.

| Reported figure | Date | Source |
| --- | --- | --- |
| $1.4B revenue | June 2026 | [Oura puts IPO on hold — here are the reasons](https://www.businessinsider.de/wirtschaft/oura-legt-boersengang-auf-eis-das-sind-die-gruende/) (businessinsider.de) |
| $1.61B revenue | June 2026 | [Smart Ring Maker Oura Files for US IPO as Revenue Surges](https://www.bloomberg.com/news/articles/2026-09-03/smart-ring-maker-oura-files-for-us-ipo-as-revenue-surges) (bloomberg.com) |
| $500M revenue | December 2024 | [Oura Health raises $875M at $11B valuation, prepping to scale smart rings globally](https://techfundingnews.com/oura-health-raises-875m-series-e-11b-valuation/) (techfundingnews.com) |

| Month | Specter estimate | Low | High |
| --- | --- | --- | --- |
| October 2026 | $1.47B | $1.08B | $2.01B |
| September 2026 | $1.42B | $1.05B | $1.92B |
| August 2026 | $1.42B | $1.1B | $1.83B |
| July 2026 | $1.39B | $1.12B | $1.73B |
| June 2026 | $1.4B | $1.16B | $1.68B |
| May 2026 | $1.32B | $960M | $1.82B |
| April 2026 | $1.25B | $960M | $1.63B |
| March 2026 | $1.18B | $920M | $1.52B |
| February 2026 | $1.12B | $860M | $1.46B |
| January 2026 | $1.06B | $840M | $1.33B |
| December 2025 | $1B | $830M | $1.2B |
| November 2025 | $940M | $520M | $1.72B |
| October 2025 | $890M | $570M | $1.4B |
| September 2025 | $840M | $540M | $1.32B |
| August 2025 | $790M | $480M | $1.32B |
| July 2025 | $750M | $480M | $1.18B |
| June 2025 | $710M | $480M | $1.05B |
| May 2025 | $670M | $460M | $970M |
| April 2025 | $630M | $450M | $890M |
| March 2025 | $590M | $440M | $800M |
| February 2025 | $560M | $440M | $720M |
| January 2025 | $530M | $430M | $660M |
| December 2024 | $500M | $420M | $600M |
| November 2024 | $250M | $114M | $380M |
| October 2024 | $190M | $80M | $300M |
| September 2024 | $197M | $84M | $310M |
| August 2024 | $183M | $81M | $290M |
| July 2024 | $176M | $86M | $270M |
| June 2024 | $171M | $85M | $260M |

## Oura valuation

Oura's valuation rose from $800M at its Series C in May 2021 to $11B at its Series E in October 2025. Specter's live estimate sits between $11.6B and $15.3B.

| Month | Specter estimate | Low | High |
| --- | --- | --- | --- |
| October 2026 | $13.3B | $11.6B | $15.3B |
| September 2026 | $10.9B | $7.53B | $15.8B |
| August 2026 | $11B | $7.74B | $15.7B |
| July 2026 | $11.1B | $8.66B | $14.2B |
| June 2026 | $11.2B | $7.94B | $15.9B |
| May 2026 | $10.8B | $7.9B | $14.7B |
| April 2026 | $10.7B | $8.16B | $14B |
| March 2026 | $10.8B | $8.45B | $13.8B |
| February 2026 | $10.9B | $8.82B | $13.5B |
| January 2026 | $11B | $9.15B | $13.2B |
| December 2025 | $11B | $8.73B | $13.9B |
| November 2025 | $11B | $8.96B | $13.5B |
| October 2025 | $11B | $9.15B | $13.2B |
| September 2025 | $10.9B | $9.11B | $13.2B |
| August 2025 | $10.3B | $7.84B | $13.5B |
| July 2025 | $9.65B | $7.41B | $12.6B |
| June 2025 | $9.06B | $7.06B | $11.6B |
| May 2025 | $8.5B | $6.74B | $10.7B |
| April 2025 | $7.98B | $6.42B | $9.92B |
| March 2025 | $7.49B | $6.1B | $9.21B |
| February 2025 | $7.04B | $5.79B | $8.55B |
| January 2025 | $6.6B | $5.47B | $7.97B |
| December 2024 | $6.2B | $5.16B | $7.45B |
| November 2024 | $5.2B | $4.33B | $6.25B |
| October 2024 | $5.08B | $2.4B | $10.7B |
| September 2024 | $4.95B | $2.55B | $9.62B |
| August 2024 | $4.83B | $2.29B | $10.2B |
| July 2024 | $4.72B | $2.75B | $8.1B |
| June 2024 | $4.61B | $2.72B | $7.81B |

| Reported valuation | Month | Source |
| --- | --- | --- |
| $11B | January 2026 | [sifted.eu](https://sifted.eu/articles/helsinki-international-tech-talent-brnd/) |
| $11B | October 2025 | Funding round |
| $10.9B | September 2025 | [techfundingnews.com](https://techfundingnews.com/oura-health-raises-875m-series-e-11b-valuation/) |
| $6.2B | December 2024 | [breakit.se](https://www.breakit.se/artikel/42082/oura-tar-in-2-miljarder-ska-dubbla-nasta-ar) |
| $5.2B | November 2024 | Funding round |
| $2.7B | August 2022 | [sifted.eu](https://sifted.eu/articles/smart-ring-oura-superapp-ambitions) |
| $2.55B | April 2022 | Funding round |
| $800M | May 2021 | Funding round |

## Oura funding rounds

| Date | Round | Raised | Post-money | Lead investors |
| --- | --- | --- | --- | --- |
| 15 Jul 2026 | Corporate round | Undisclosed | Undisclosed | Eli Lilly |
| 14 Oct 2025 | Series E | $900M | $11B | Fidelity |
| 22 Sep 2025 | Debt financing | $250M | Undisclosed | Undisclosed |
| 19 Nov 2024 | Series D | $200M | $5.2B | Fidelity, Dexcom |
| 5 Apr 2022 | Venture round | Undisclosed | $2.55B | Undisclosed |
| 4 May 2021 | Series C | $100M | $800M | Elysian Park Ventures, TCG |
| 17 Mar 2020 | Series B | $28M | Undisclosed | Forerunner, Gradient |
| 3 Oct 2018 | Series A | $6M | Undisclosed | DFO Management |
| 1 Apr 2018 | Series A | $6.16M | Undisclosed | Tesi, Bold Capital Partners |
| 30 Sep 2016 | Series A | $5.62M | Undisclosed | Jaan Tallinn, Harpreet Singh Rai, Lateralus Holdings |
| 11 Nov 2015 | Seed | $2.3M | Undisclosed | Lifeline Ventures |

## Oura vs competitors

The smart ring market splits between general wellness tracking and clinical-grade health diagnostics.

| Company | Estimated revenue | Estimated valuation |
| --- | --- | --- |
| Oura | $1.08B–$2.01B | $11.6B–$15.3B |
| Ultrahuman (ultrahuman.com) | $111M–$175M | $330M–$480M |
| RingConn (ringconn.com) | $3.4M–$16M | $20M–$121M |
| Gabit (gabit.com) | $5.6M–$19M | $53M–$91M |
| Circular (circular.xyz) | $1.1M–$5.3M | $3.7M–$18M |

## Questions

### What is Oura's revenue?

Specter estimates Oura's annual revenue at $1.08B to $2.01B as of October 2026. Oura last reported $1.4B revenue in June 2026, up from $500M in December 2024.

### What is Oura's valuation?

Oura's latest post-money valuation is $11B, from an October 2025 Series E. Specter's live estimate is $11.6B to $15.3B.

### What is Oura's revenue multiple?

Oura is valued at about 7.9× revenue, based on its $11B October 2025 valuation and $1.4B last reported revenue. That works out to roughly $848K of revenue per employee.

### How much funding has Oura raised?

$1.5B across 11 rounds, from a $2.3M Seed in November 2015 to a corporate round in July 2026.

### Who invested in Oura?

64 investors, including Dexcom, Eli Lilly, Elysian Park Ventures, Fidelity, Forerunner and TCG.

### Who are Oura's competitors?

Ultrahuman, RingConn, Gabit and Circular. Specter ranks 30 competitors for Oura.

## About this data

Specter models revenue and valuation monthly and anchors each estimate to reported figures and priced rounds. Method: https://www.tryspecter.com/revenue-valuation

Cite as: Specter. "Oura revenue and valuation." tryspecter.com/revenue-valuation/oura. Updated November 2026.